| Date Filed | Type | Description |
| 05/23/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 6,403 shares
@ $58.9553, valued at
$377.5k
Sold 1,913 shares
@ $58.9783, valued at
$112.8k
Sold 100 shares
@ $59.66, valued at
$6k
|
|
| 05/19/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 800 shares
@ $58.5175, valued at
$46.8k
Sold 7,248 shares
@ $58.5, valued at
$424k
Sold 788 shares
@ $58.7143, valued at
$46.3k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 375 shares
@ $45.628, valued at
$17.1k
|
|
| 01/26/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 359 shares
@ $47.4513, valued at
$17k
|
|
| 01/12/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 663 shares
@ $42.9329, valued at
$28.5k
Sold 571 shares
@ $44.3596, valued at
$25.3k
|
|
| 01/11/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 858 shares
@ $41.6562, valued at
$35.7k
|
|
| 01/09/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 18,000 shares
@ $0
Granted 45,000 options to buy
@ $39.42, valued at
$1.8M
|
|
| 04/21/2022 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 822 shares
@ $42.515, valued at
$34.9k
|
|
| 01/27/2022 |
4
| Pauwels Eric (Chief Business Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 359 shares
@ $39.314, valued at
$14.1k
|
|
| 01/11/2022 |
4
| Pauwels Eric (Chief Business Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 866 shares
@ $38.525, valued at
$33.4k
Granted 16,800 shares
@ $0
Granted 63,000 options to buy
@ $38.1, valued at
$2.4M
|
|
| 01/06/2022 |
4
| Pauwels Eric (Chief Business Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 806 shares
@ $41.162, valued at
$33.2k
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Pauwels Eric (Chief Business Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 431 shares
@ $62.054, valued at
$26.7k
|
|
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2020 |
4
| Pauwels Eric (Chief Business Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 6,194 shares
@ $56.5, valued at
$350k
|
|
| 04/17/2020 |
4
| Pauwels Eric (Chief Business Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0
Granted 50,000 options to buy
@ $47.49, valued at
$2.4M
|
|
| 04/17/2020 |
3
| Pauwels Eric (Chief Business Officer) has filed a Form 3 on PTC THERAPEUTICS, INC. |
| 02/24/2015 |
4
| Pauwels Eric (President, NPS Pharma Int'l) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 30,029 shares
@ $46, valued at
$1.4M
Disposed/sold 22,099 options to buy
@ $38.27, valued at
$845.7k
Disposed/sold 55,564 options to buy
@ $8.23, valued at
$457.3k
Disposed/sold 6,475 options to buy
@ $8.21, valued at
$53.2k
Disposed/sold 160,000 options to buy
@ $6.92, valued at
$1.1M
Disposed/sold 4,362 restricted stock units
@ $0
Disposed/sold 5,575 restricted stock units
@ $0
Disposed/sold 8,101 restricted stock units
@ $0
Disposed/sold 10,000 rights
@ $0 |
|
| 02/20/2015 |
4
| Pauwels Eric (President, NPS Pharma Int'l) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 4,867 shares
@ $0
Paid exercise price by delivering 1,662 shares
@ $45.85, valued at
$76.2k
Paid exercise price by delivering 957 shares
@ $45.85, valued at
$43.9k
Paid exercise price by delivering 3,005 shares
@ $45.88, valued at
$137.9k
Exercised 2,787 restricted stock units
@ $0
Granted 4,362 restricted stock units
@ $0
Exercised 8,100 restricted stock units
@ $0 |
|
| 09/30/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/05/2014 |
4
| Pauwels Eric (President, NPS Pharma Int'l) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 620 shares
@ $27.86, valued at
$17.3k
Exercised 1,667 rights
@ $0 |
|
| 05/07/2014 |
4
| Pauwels Eric (President, NPS Pharma Int'l.) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 1,667 rights
@ $0 |
|
| 02/14/2014 |
4
| Pauwels Eric (SVP & Chief Commercial Officer) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,828 shares
@ $38.3, valued at
$108.3k
Granted 22,890 options to buy
@ $38.27, valued at
$876k
Granted 8,362 restricted stock units
@ $0
Exercised 8,100 restricted stock units
@ $0 |
|
| 02/11/2014 |
4
| Pauwels Eric (SVP & Chief Commercial Officer) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 4,867 shares
@ $0
Paid exercise price by delivering 1,759 shares
@ $35.13, valued at
$61.8k
|
|
| 02/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2013 |
4
| Pauwels Eric (SVP & Chief Commercial Officer) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 4,866 shares
@ $0
Paid exercise price by delivering 1,929 shares
@ $8.61, valued at
$16.6k
|
|
| 09/27/2011 |
4
| Pauwels Eric (Chief Commercial Officer) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 09/27/2011 |
3
| Pauwels Eric (Chief Commercial Officer) has filed a Form 3 on NPS PHARMACEUTICALS INC |
| 01/27/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |